These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7875287)

  • 1. Salmeterol-induced vertigo.
    López-Guillen A; Marquès L; López-Llorente MT; Pastor E; Figueras A
    Eur Respir J; 1994 Nov; 7(11):2089-90. PubMed ID: 7875287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salmeterol for the treatment of asthma.
    Weinberger M
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):209-11. PubMed ID: 7552921
    [No Abstract]   [Full Text] [Related]  

  • 3. Life-threatening asthma during treatment with salmeterol.
    Weinberger M; Abu-Hasan M
    N Engl J Med; 2006 Aug; 355(8):852-3. PubMed ID: 16929006
    [No Abstract]   [Full Text] [Related]  

  • 4. Salmeterol versus theophylline in the treatment of asthma.
    Pollard SJ; Spector SL; Yancey SW; Cox FM; Emmett A
    Ann Allergy Asthma Immunol; 1997 May; 78(5):457-64. PubMed ID: 9164358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group.
    Britton MG; Earnshaw JS; Palmer JB
    Eur Respir J; 1992 Oct; 5(9):1062-7. PubMed ID: 1426215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of single therapeutic and supratherapeutic doses of indacaterol versus salmeterol and salbutamol in patients with asthma.
    Brookman LJ; Knowles LJ; Barbier M; Elharrar B; Fuhr R; Pascoe S
    Curr Med Res Opin; 2007 Dec; 23(12):3113-22. PubMed ID: 17999782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
    Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salmeterol.
    Med Lett Drugs Ther; 1994 Apr; 36(921):37-9. PubMed ID: 7909139
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence based answers--is salmeterol safe in asthma?
    Spurling G; Doust J
    Aust Fam Physician; 2006 Aug; 35(8):625-6. PubMed ID: 16894440
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy, safety, and impact on quality of life of salmeterol in patients with moderate persistent asthma.
    Busse WW; Casale TB; Murray JJ; Petrocella V; Cox F; Rickard K
    Am J Manag Care; 1998 Nov; 4(11):1579-87. PubMed ID: 10338904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy. UK Study Group.
    Boyd G
    Eur Respir J; 1995 Sep; 8(9):1494-8. PubMed ID: 8575574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma.
    Bateman ED; Kornmann O; Schmidt P; Pivovarova A; Engel M; Fabbri LM
    J Allergy Clin Immunol; 2011 Aug; 128(2):315-22. PubMed ID: 21807250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma.
    Wenzel SE; Lumry W; Manning M; Kalberg C; Cox F; Emmett A; Rickard K
    Ann Allergy Asthma Immunol; 1998 Jun; 80(6):463-70. PubMed ID: 9647268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salmeterol: its place in asthma management.
    Kamada AK; Spahn JD; Blake KV
    Ann Pharmacother; 1994 Sep; 28(9):1100-2. PubMed ID: 7803888
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serevent. Salmeterolxinafoate].
    Madl ML
    Wien Klin Wochenschr; 1993; 105(16):476-81. PubMed ID: 8212706
    [No Abstract]   [Full Text] [Related]  

  • 17. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life.
    Rutten-van Mölken MP; Custers F; van Doorslaer EK; Jansen CC; Heurman L; Maesen FP; Smeets JJ; Bommer AM; Raaijmakers JA
    Eur Respir J; 1995 Jun; 8(6):888-98. PubMed ID: 7589374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma.
    Pearlman DS; Chervinsky P; LaForce C; Seltzer JM; Southern DL; Kemp JP; Dockhorn RJ; Grossman J; Liddle RF; Yancey SW
    N Engl J Med; 1992 Nov; 327(20):1420-5. PubMed ID: 1357554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of time on the perception of dyspnea following inhaled long-acting bronchodilator].
    Weiner P; Magadle R; Beckerman M; Berar-Yanay N
    Harefuah; 2003 May; 142(5):342-4, 398. PubMed ID: 12803056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.